All patients (n=25) Male sex 21 (84%) Age (years) 56 ± 10 Hypertension • Systolic blood pressure (mmHg) • Diastolic blood pressure (mmHg) 10 (40%) 137 ± 23 78 ± 13 Diabetes 2 (8%) Hypercholesterolemia (mmol/l) 4 (16%) • Total cholesterol • HDL cholesterol • LDL cholesterol • Triglycerides 5.6 ± 0.9 1.4 ± 1.3 3.6 ± 1.0 2.0 ± 1.5 Current smoking 10 (40%) Positive family history of CAD Cardiovascular medication at admission • Betablocker • Calcium antagonist • Ace-/Angiontension inhibitor • Statin • Diuretic 16 (64%) 1 (4%) 1 (4%) 0 (0%) 2 (8%) 1 (4%) Culprit lesion   • LAD 9 (36%) • LCX 3 (12%) • RCA 13 (52%) Time to revascularization (hours) 3.7 ± 1.5 CK max (U/l) 1026 (176-8074) LV hypertrophy on ECG 0 (0%) Infarct age (months) 5.6 ± 0.6 Framingham Risk Score 14.1 ± 5.8

Table 1: Patient baseline characteristics. Continuous data are expressed as mean ± standard deviation or median with range if appropriate; and categorical data as frequencies and percentage. HDL = high density lipoprotein, LDL=low density lipoprotein, CAD = coronary artery disease, LAD = left anterior descending, LCX = left circumflex, RCA = right coronary artery, CK = creatine kinase, LV = left ventricle, ECG = electrocardiogram.